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1
To assess the role of Fas in lesion development during genital HSV-2 infection, we used a well-established HSV-2 murine model
applied to MRL-Fas
lpr/J (Fas / ) and C3-Fasl
gld/J (FasL / ) C57BL6 mice. In vitro infection of murine keratinocytes and
epithelial cells was used to clarify molecular details of HSV-2 infection. Despite upregulation of Fas and FasL, HSV-2-infected
keratinocytes and epithelial cells showed a moderate level of apoptosis due to upregulated expression of the anti-apoptotic
factors Bcl-2, Akt kinase and NF-jB. Inﬂammatory lesions within the HSV-2-infected epithelium of C57BL6 mice consisted of
infectedcellsupregulatingFas,FasLandBcl-2,uninfectedcellsupregulatingFasandneutrophilsexpressingbothFasandFasL.
ApoptosiswasdetectedinHSV-2-infectedcellsandtoevenhigherextentinnon-infectedcellssurroundingHSV-2infectionsites.
HSV-2 infection of Fas- and FasL-deﬁcient mice led to increased apoptosis and stronger recruitment of neutrophils within the
infectionsites.WeconcludethattheFaspathwayparticipatesinregulationofinﬂammatoryresponseinthevaginalepithelium at
the initial stage of HSV-2 infection.
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Herpes simplex viruses (HSV) type 1 and 2 are among the
DNA viruses interfering at multiple levels with cellular
apoptotic processes important for cellular response to virus
infection.
1 Moderate level of apoptosis were however
observed in HSV-2-infected epithelial cells, in contrast to
HSV-1-infected cells, which displayed consistent levels of
apoptosis.
2 HSV-2-mediated apoptosis occurs during HSV-2
infection both in vivo – in dorsal root ganglia and spinal cord
pituitary gland
3– and in vitro – in peritoneal macrophages,
4
monocytes,
5 dendritic cells
6 and human peripheral blood
mononuclear cells (PBMCs).
7 Other studies, however, have
concluded that HSV-2 can prevent apoptosis in a manner
similar to HSV-1 and that the viral US3 protein kinase
8 and
the ribonucleotide reductase
9 participate in blocking of the
apoptotic process. Furthermore, it was shown that HSV-2
ICP10PK protein, which has a role in establishment of virus
latency andreactivation, inhibits caspase-3activation through
its ability to activate Ras and the downstream survival
pathways Raf-1/MEK/ERK and PI3-K/Akt.
9,10
Clinical and laboratory HSV-2 strains both induced, and
subsequently blocked, apoptosis in infected HEp-2 epithelial
cells and these biological features were correlated with NF-kB
translocation to the nuclei of HSV-2-infected cells.
11 Infection
of human keratinocyte cell line HaCaT with HSV-1 and HSV-2
led to a signiﬁcant increase of apoptosis,
12 an event
depending on the p63 protein, involved in the maintenance
of stratiﬁed epithelial tissues. Together, these observations
suggest that whether HSV-2 infection leads to apoptotic cell
death or not, depends on the cell type.
The Fas/FasL system has an important role in skin and
epithelial homeostasis, carcinogenesis and inﬂammatory skin
diseases.
13,14 Epidermal keratinocytes express Fas but not
FasL.
15 Abnormal expression of lytically active FasL was
however found in inﬂammatory skin diseases as toxic
epidermal necrolysis, atopic dermatitis and allergic contact
dermatitis.
13,14,16 FasL elicited a proinﬂammatory reaction in
humankeratinocyteHaCaTcelllineandreconstructedhuman
epidermis by triggering the expression of stress-responsive
transcriptionfactorsandinﬂammatorycytokinesinabsenceof
an apoptotic response.
17
HSV-2, but not HSV-1, was shown to inhibit cell surface
expression of FasL in PBMCs and K562 leukemic cell line.
18
However, in vivo clearance of HSV-2 infection in a murine
model requires Fas and perforin-dependent cytotoxic
mechanisms, as mice lacking both perforin- and Fas-
mediated cytolytic mechanisms were unable to completely
clear the infection from the vaginal tissue.
19 The role of Fas/
FasL system in the vaginal epithelium may thus not only be
limited to the elimination of HSV-2 infected cells via apoptosis
but also related to the development of inﬂammatory lesions
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We assessed the role of Fas during HSV-2 vaginal infection
using keratinocytes and epithelial cells in vitro and a murine
model of genital herpes. In vitro, HSV-2-infected cells
upregulated Fas and FasL and anti-apoptotic proteins
(Bcl-2, NF-kB, Akt kinase) and displayed moderate levels of
apoptosisonly during the later stageof infection.Upregulation
of Fas, FasL and Bcl-2 was noticed in the HSV-2-infected
epithelium of C57BL/6 mice. In the mice, the cells undergoing
apoptosis were infected cells present at the site of the lesions
and uninfected, Fas-expressing, epithelial cells surrounding
the HSV-2-infected sites. Experiments performed in HSV-2-
infected Fas ( / ) and FasL ( / ) C57BL mice showed a
reduced level of apoptosis among uninfected cells and an
increased inﬁltration of neutrophils at the vaginal site. Our
results suggest a role for Fas/FasL in the regulation of
inﬂammatory responses at the early stages of vaginal HSV-2
infection.
Results
HSV-2 infection induces moderate levels of apoptosis
in epithelial cells and keratinocytes. A signiﬁcantly higher
number of cells, with caspase-3-speciﬁc cytokeratin 18
cleavage (M30-positive cells), was found in HSV-2-infected
mouse keratinocytes (291.03C) and epithelial cells (Hepa
1–6) at 24 and 48h postinfection (p.i.) in comparison with
uninfected cultures (Pr0.05) (Figure 1a). Interestingly, in
spite of the fact that both infected epithelial and keratinocyte
cultures underwent apoptosis, the total cell number in these
cultures was comparable to the control cell cultures
(Figure 1b).
At 24h p.i. (HSV-2 MOI 1–10), the number of HSV-2-
infected cells reached approximately 80% of cells in culture
(Figure 1c). Of these, 48.23±2.34% of HSV-2-infected
epithelial cells and 45.89±4.01% of HSV-2-infected keratino-
cytes showed apoptotic features at 24h p.i. (Figure 1d).
At 48h p.i., the population of HSV-2-infected epithelial
Apoptosis in HSV-2 infected cultures
keratinocytes
epithelial cells
uninfected cells
uninfected
infected
Cell numbers in HSV-2 infected cultures
40
60
80
100
0
20
%
 
o
f
 
M
3
0
-
p
o
s
i
t
i
v
e
 
c
e
l
l
s
hours after infection
4
6
8
10
0
2
epithelial cells
l
o
g
 
1
0
 
c
e
l
l
 
n
u
m
b
e
r
/
w
e
l
l
HSV-2 infected cells
epithelial cells
keratinocytes keratinocytes
epithelial cells
HSV-2 infected cells undergoing apoptosis
in cultures
60
80
100
0
20
40
24
%
 
H
S
V
-
2
-
p
o
s
i
t
i
v
e
 
c
e
l
l
s
hours after infection
60
80
100
0
20
40
0
%
 
M
3
0
-
p
o
s
i
t
i
v
e
 
c
e
l
l
s
hours after infection
Protection from staurosporine (ST) induced
apoptosis
keratinocytes
epithelial cells
60
80
100
0
20
40
%
 
M
3
0
-
p
o
s
i
t
i
v
e
 
c
e
l
l
s
0 12 24 48 keratinocytes
48 24 48
control ST HSV-2 HSV-2 + ST HSV-2/-4h/+ST
Figure 1 (a) Kinetics of total percentage of M30-positive (apoptotic) cells in epithelial Hepa 1–6 and keratinocyte 03C cell cultures during 48h after infection with HSV-2,
(b) the total cell number in cultures of HSV-2-infected epithelial cells and keratinocytes (at 24h p.i.) and in control, uninfected cultures, (c) the total percentage of HSV-2-
infected cells in epithelial and keratinocyte cell cultures at 24 and 48h p.i., (d) double-positive M30/HSV-2 cells in HSV-2-infected epithelial and keratinocyte cultures during
48h of infectionwith HSV-2.(e)Percentageof M30-positivecellsin epithelialHepa 1–6and keratinocyte03Ccell culturessubjectedto ST(5mM), infectedornot, with HSV-2
for 18 or 22h (including 4h infection, before staurosporine treatment) at MOI¼1. Each bar represents the mean of ﬁve independent experiments (N¼5)±S.E.M.
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Cell Death and Diseasecells, corresponding to 90% of cells in culture (Figure 1c),
included 56.55±6.78% of apoptotic cells (Figure 1d),
whereas HSV-2-infected keratinocytes included 34.93±
1.29% of apoptotic cells (Pr0.05) (Figure 1d). These results
show that at 48h of infection, the rate of apoptosis in
keratinocyte cultures decreased and in the culture remained
a population of HSV-2-infected, non-apoptotic cells. HSV-2-
infected epithelial cells and keratinocytes (Figure 1e) were
not susceptible to staurosporine (ST)-induced apoptosis
if the treatment with ST was initiated later than 4h p.i., thus
indicating that HSV-2 induces an apoptosis-resistant
status in the infected epithelial cells and keratinocytes within
hours from infection through the induction of anti-apoptotic
proteins.
Taking into account that HSV-2-infected cells of epithelial
and neuronal origin activate anti-apoptotic mechanisms
dependent on Bcl-2-family and NF-kB and PI3-K/Akt path-
ways,
11,20 we assessed the expression of Bcl-2, NF-kB and
Akt in HSV-2-infected epithelial cells and keratinocytes. We
found that Bcl-2 was signiﬁcantly upregulated in both types of
cells during the entire tested period in comparison with
uninfected cells (Pr0.05) (Figure 2a). In our experimental
conditions,bothHSV-2-infectedcelllinesshowedasigniﬁcant
increase in NF-kB activation, especially at 6h of infection, in
comparison with uninfected cells (Pr0.05) (Figure 2b).
Between 6 and 18h p.i., NF-kB activation decreased to levels
close to baseline (Pr0.05) (Figure 2b). Similarly, a signiﬁ-
cantly increased activity of the anti-apoptotic Akt kinase
(Pr0.05) occurred in HSV-2-infected epithelial and keratino-
cyte cultures (Figure 2c).
HSV-2-infected epithelial cells and keratinocytes
upregulate Fas and FasL but do not die through this
receptor pathway. Upon infection with HSV-2, mouse
keratinocyte and epithelial cell cultures signiﬁcantly
upregulated both Fas and FasL (Pr0.05) (Figures 3a
and b). To assess whether HSV-2-infected cells may
inﬂuence Fas expression on uninfected cells, we used
HSV-2 at MOI 0.1, which resulted in 50% of HSV-2-
infected cells and 50% of non-infected cells in culture. The
intensity of Fas expression was not only higher for HSV-2-
infected cells (P¼0.001) but also increased for non-infected
cells at 24h p.i. (P¼0.013) (Figure 3c). A similar picture was
also observed for keratinocytes, with a signiﬁcant increase in
Fas expression on both non-infected (P¼0.01) and infected
cells (P¼0.004) (Figure 3c).
To assess the sensitivity of HSV-2-infected epithelial cells
and keratinocytes to Fas-induced apoptosis we used an anti-
mouse Fas cytotoxic antibody (Jo-1 clone). In both the Hepa
1–6 epithelial cell cultures and in keratinocytes, addition of the
anti-Fas antibody to uninfected cultures resulted in an
increased percentage of annexin V-positive cells after 24h
(Po0.001) (Figures 4a and b). Addition of anti-Fas antibody
to HSV-2-infected cultures also signiﬁcantly increased
Fas-mediated apoptosis (Po0.05) (Figures 4a and b). FasL
blocking antibody (clone MFL-4) did not decrease the
numbers of apoptotic cells in HSV-2-infected epithelial cells
and keratinocytes (Figures 4a and b).
Fas/FasL system has an important role in apoptosis of
keratinocytes in the skin,
14 and keratinocytes are the main
target cells for both HSV-1 and HSV-2.
21 Therefore, we used
the anti-mouse Fas cytotoxic antibody Jo-1 to study the
involvement of Fas in apoptosis of HSV-2-infected and
uninfected keratinocytes. Addition of the anti-Fas antibody
led to a signiﬁcant decrease in HSV-2-infected cells at 24h of
infection (P¼0.02) (Figure 4c), whereas addition of anti-FasL
blocking antibody (MFL-4) caused a signiﬁcant increase of
HSV-2-positive cells (P¼0.032) (Figure 4c). To verify
whether the decrease in HSV-2-infected cells occurring upon
incubation with the cytotoxic anti-Fas antibody could result
from bystander apoptosis of uninfected cells, we measured
apoptosis in cultures infected with HSV-2 at MOI 0.1, when
only 50% of cells were infected at 24h p.i. (Figure 4d).
Although more HSV-2-infected cells underwent apoptosis in
the cultures incubated with anti-Fas and anti-FasL antibodies,
this difference was not statistically signiﬁcant (Figure 4d). On
the contrary, in presence of cytotoxic anti-Fas antibody, more
uninfected cells were apoptotic in comparison with untreated
control cells and cells treated with FasL blocking antibody
(Pr0.05) (Figure 4d).
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Figure 2 Relative kinetics of Bcl-2 expression (a) and levels of active NF-kB
(b) in epithelial Hepa 1–6 and keratinocyte 03C cell cultures infected with HSV-2.
(c) Percentage of cells with active, phosphorylated form of Akt in HSV-2-infected
epithelial Hepa 1–6 and keratinocyte 03C cell cultures. The presented values for
HSV-2-infected cultures were subtracted from the values obtained at the same time
point for the uninfected cultures. Each bar represents the mean from ﬁve
experiments (N¼5)±S.E.M.
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Cell Death and DiseaseFas is involved in the development of inﬂammatory
mucosal lesions in vivo. During HSV-2 infection of C57BL/
6 mice, the vaginal mucosa is subjected to development of
lesions, compromising its integrity and ability to protect from
the virus attack.
22 In our experiments, HSV-2-infected sites
were present within the vaginal epithelium of C57BL/6 mice
at 3 days of infection. Staining of the vaginal tissues showed
that HSV-2-infected cells in the epithelium upregulated both
Fas and FasL (Figures 5a and b), whereas non-infected cells
surrounding the HSV-2-infected cells upregulated only Fas
(Figures 5a and b). Fas and FasL expressions were also
upregulated on Gr-1-positive cells (neutrophils), with only
Fas showing a signiﬁcant increase (P¼0.01) (Figure 5c). In
HSV-2-infected sites, apoptotic cells, deﬁned as TUNEL-
positive, were found not only among HSV-2-positive cells but
also among non-infected cells (Figure 6a).
To estimate the role of Fas and FasL in the development of
vaginal epithelium lesions induced by HSV-2, we infected
mice with either a knockout in Fas gene (B6.MRL-Fas
lpr/J) or
a knockout in FasL gene (B6Smn.C3-Fasl
gld/J) together with
the control background strain (C57BL/6). The control, un-
infected Fas ( / ) mice presented with a thin vaginal
epithelium, consisting of densely packed cells, whereas
uninfected FasL ( / ) mice showed no progesterone-
dependent thinning of the epithelium (Figure 6a). In both
Fas and FasL knockout mice, the HSV-2-infected epithelium
was shedding off (Figure 6a) and apoptotic bodies could be
found at all inﬂammatory sites (Figure 6a). A signiﬁcantly
higher number of TUNEL-positive cells were, however, found
at the HSV-2-infected sites in Fas- and FasL-deﬁcient mice
(Figure 6b). The comparison of Fas- and FasL-deﬁcient mice
revealed that Fas ( / ) and FasL ( / ) mice showed more
infected TUNEL-positive cells at the HSV-2-infected sites
(Figure 6c). In Fas and FasL knockout mice, a signiﬁcant
increase in inﬁltrating Gr-1-positive cells (neutrophils) was
found within the HSV-2-infected epithelium, in comparison
with infected wild-type (WT) mice (Pr0.05) (Figure 6d).
A PCR method was used to measure DNA titers in vaginal
lavages collected at day 2 of infection in mice; the results
showed no differences in the titers of HSV-2 shed into the
vaginal lumen in WT and Fas- and FasL-deﬁcient mice
(Figure 6e). To verify whether Bcl-2 expression is affected by
the depletion of Fas and FasL, we stained for Bcl-2 during
HSV-2 infection of the knockout mice. The stainings detected
a common pattern of Bcl-2 expression in the middle part of the
infection sites in all infected mice strains (Figure 6f).
Fas is involved in the regulation of keratinocyte
inﬂammatory response in vitro. To assess whether
stimulation through the Fas/FasL pathway inﬂuences the
induction of inﬂammatory responses by HSV-2-infected
keratinocytes and epithelial cells, we evaluated the
expression of CXCL1/2 chemokines, TNF-a and IL-1b
cytokines. HSV-2 infection of keratinocytes in vitro led to a
signiﬁcant upregulation of CXCL1/2, TNF-a and IL-1b
expression at 18h of infection (Pr0.001) (Figures 7a–c),
whereas HSV-2-infected epithelial cells upregulated
CXCL1/2 (Figure 7d), TNF-a and IL-1b (data not shown).
Addition of anti-Fas cytotoxic antibody to control uninfected
keratinocytes led to a signiﬁcant upregulation of CXCL1/2
and TNF-a expression at 18h of incubation (Pr0.001)
(Figures 7a and b). Interestingly, addition of the cytotoxic
anti-Fas antibody to HSV-2-infected keratinocyte and
epithelial cultures signiﬁcantly abrogated CXCL1/2
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Cell Death and Diseaseexpression, whereas, upon these conditions, TNF-a and
IL-1b expression was abrogated only in keratinocytes
(Pr0.05, Figures 7a–d).
To analyze how the blocking of Fas/FasL interaction
inﬂuences CXCL1/2, TNF-a and IL-1b expression in HSV-2-
infected keratinocyte, we used an anti-FasL blocking anti-
body. The anti-FasL blocking antibody showed no inﬂuence
on CXCL1/2, TNF-a and IL-1b expression in uninfected
keratinocytes and epithelial cells (Figures 7a–d). The bio-
logical effect of the anti-FasL blocking antibody was signiﬁcantly
different in HSV-2-infected cells. In fact, upon blocking of
FasL, the HSV-2-infected keratinocytes signiﬁcantly upregu-
lated CXCL1/2 and IL-1b expression (Pr0.05), but not TNF-a
(Figures 7a–c). HSV-2-infected epithelial cells incubated with
anti-FasL blocking antibody signiﬁcantly upregulated only
CXCL1/2 (Pr0.05) (Figure 7d).
To verify whether the inﬂammatory cytokines and
chemoattractants produced from keratinocytes infected and/
or stimulated with the cytotoxic anti-Fas antibody exerted a
chemotactic role for migration of neutrophils into HSV-2-
infected vaginal tissue, we allowed neutrophils to migrate
toward keratinocytes subjectedto different stimuli (Figure 7e).
The transwell experiment showed that Fas stimulation of
uninfected and HSV-2-infected keratinocytes induced a
signiﬁcant migration of Gr-1-positive cells, in comparison with
migration toward control, uninfected cells (Pr0.001)
(Figure 7e). FasL blocking antibody signiﬁcantly upregulated
migration toward HSV-2-infected cells (Pr0.05), whereas
Fas-stimulating antibody signiﬁcantly decreased migration
toward HSV-2-infected keratinocytes (Pr0.001) (Figure 7e).
Furthermore, staining for CXCL1/2 and IL-1b of the vaginal
tissues from HSV-2-infected WT, Fas- and FasL-deﬁcient
mice showed a signiﬁcantly increased numbers of
both infected and uninfected cells expressing CXCL1/2
(Figures 7f and g) and IL-1b (Figures 7f and g) in Fas- and
FasL-deﬁcient mice (Pr0.05).
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Cell Death and DiseaseDiscussion
The goal of this study was to investigate the role of Fas
pathway during in vitro HSV-2 infection of mouse keratinocyte
and epithelial cells and during in vivo HSV-2 vaginal infection
of mice. In our study, both epithelial cells and keratinocytes
underwent moderate apoptosis upon HSV-2 infection but not
earlier than 12h p.i. because of the induction of anti-apoptotic
pathways early during infection. Indeed, we could observe
NF-kB induction already at 6h p.i. in both cell lines together
with upregulated expression of the anti-apoptotic factor Bcl-2.
Decreased NF-kB levels could be observed before apoptosis
induction, remaining at low levels throughout the follow-up
time of infection in both types of infected cell cultures.
Activation of the NF-kB transcription factor is one of the
anti-apoptotic mechanisms operating in epidermis and
epithelial cells.
11,14,23 Observations similar to the ﬁndings
presented in this paper were made during infection with
HSV-1, whose genome is collinear with HSV-2.
24,25
PI3K/Akt signaling is important in apoptosis suppression of
epithelial cells and keratinocytes.
14,26 In HSV-2-infected
cultures of epithelial cells and keratinocytes, we detected an
increase in cells positive for the active form of Akt kinase, thus
implying a role for this kinase in apoptosis suppression during
the later stages of HSV-2 infection in vitro. The involvement
of Akt in protection from apoptosis was previously shown for
HSV-2-infected neurons
27 and during HSV-1 infection of
human epithelial HEp-2 cells.
28 Bcl-2 overexpression
increased the capacity of HSV-2-infected monocytoid cells
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infected Fas ( / ), FasL ( / ) and WT (C57BL/6) mice at day 2 of infection. (f) Bcl-2 expression (green) and HSV-2 antigen localization (red) in the vaginal tissue isolated
from HSV-2-infected Fas ( / ), FasL ( / ) and WT (C57BL/6) mice at 3 days of infection. The nuclei were counterstained with Hoechst 33342 (blue). The bars represent
mean from three separate experiments (N¼3)±S.E.M. *Represents signiﬁcant differences with Pr0.05, **Pr0.001
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Cell Death and Diseaseto sustain a fully productive infection, while protecting against
HSV-2-induced apoptosis.
29 In our experiments, Bcl-2
expression was upregulated during the initial 12h of infection,
to remain at a stable, low level in the analyzed period. The
induction of anti-apoptotic genes, during early events of
HSV-2 infection of epithelial cells and keratinocytes, was
veriﬁed by experiments conducted in presence of the
proapoptotic substance ST.
It was previously shown
30 that human epithelial HEp-2 cells
infected with HSV-1 were resistant to Fas-induced apoptosis.
In our study, HSV-2-infected murine epithelial cells and
keratinocytes upregulated Fas and FasL. This event should
render the HSV-2-infected cells sensitive to apoptosis
delivered either by FasL present on neighboring cells or
through an autocrine pathway (Figure 8). However, a closer
analysis showed that induction of apoptosis in the infected
epithelial and keratinocytes cultures by a cytotoxic Fas
antibody involved a large portion of uninfected cells, which
also upregulated Fas, therefore leading to a decrease in the
number of potential target cells for HSV-2 infection; this
process could be diverted by the addition of FasL blocking
antibody. These results show that HSV-2-infected cells are
relatively resistant to Fas-induced apoptosis and that cell
death of these cells likely occurs through other pathways.
Fleck et al.
4 also showed that, although murine macrophages
upregulated Fas and TNFR1 receptors upon HSV-2 infection,
inhibition of Fas by addition of soluble Fas and blocking of
TNF-a did not prevent HSV-2-induced apoptosis. In the
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Cell Death and Diseasehuman T-cell line Jurkat, HSV-2 induced apoptosis through
extrinsic (death receptors) and intrinsic (mitochondrial) path-
ways.
31 Therefore, it is likely that mitochondrial pathway may
also be involved in apoptosis during HSV-2 infection of
epithelial cells and keratinocytes.
The role of Fas/FasL in induction of apoptosis is generally
recognized.
32 However, evidence accumulates on Fas as a
mediator of apoptosis-independent processes, including
proliferation, angiogenesis, ﬁbrosis and inﬂammation.
33 In
cellsresistant toFas-inducedapoptosis, activationofFaswas
shown to induce activation of PI3K/AKT pathway, ultimately
leading to cell migration.
34 Therefore, it is possible that
keratinocytes may possess the ability to activate non-
apoptotic pathways through Fas receptor.
In our experimental model, consisting of murine keratino-
cyte 03C cells, we demonstrated an increased expression of
CXCL1/2, TNF-a and IL-1b in HSV-2-infected keratinocytes.
Interestingly, the expression of CXCL1/2 and TNF-a also
increased signiﬁcantly when uninfected keratinocytes were
stimulatedwiththecytotoxicFasantibodyshowingtheirability
to mount a proinﬂammatory response mediated through the
Fas-dependent pathway (Figure 8). However, the combina-
tion of HSV-2 infection and paracrine stimulation of the Fas
pathway led to downregulation of the proinﬂammatory
response. On the contrary, blocking of FasL during HSV-2
infection of keratinocytes led to upregulation of CXCL1/2
and IL-1b responses. The production of the inﬂammatory
cytokinesandchemoattractantswasreﬂectedinthemigration
of Gr1-positive cells toward infected keratinocytes, in that
both HSV-2 infection and anti FasL blocking antibody were
important mediators for this phenomenon. Furthermore, the
HSV-2-infected sites in Fas- and FasL-deﬁcient mice showed
a stronger expression of CXCL1/2 and IL-1b in comparison
with HSV-2-infected WT mice, indicating the role of Fas/FasL
in regulation of the inﬂammatory responses within the vaginal
mucosa (Figure 8).
CXCL1 and CXCL2 expression is upregulated in the vagina
and in the CNS of mice during acute HSV-2 infection.
35
These chemokines speciﬁcally targets neutrophils through
the CXCR2 receptor, promoting their chemotaxis and
activation.
35 IL-1b and TNF-a facilitate the recruitment of
neutrophils to inﬂammatory sites and TNF-a stimulates
differentiation of natural killer (NK) cells, a cell population
critical in the control of genital HSV-2 infection.
36,37
Vaginal lesions developed during HSV-2 infection destroy
the integrity of the local mucosa and lead to increased
inﬁltration of different types of innate immune cells, including
NK cells, macrophages and neutrophils. In our study we
considered the possibility that Fas/FasL system may be
directly involved in the development of vaginal lesions, as part
of apoptosis induction following HSV-2 infection of mice. The
HSV-2-infected epithelial cells upregulated Fas, FasL and
also Bcl-2 in vivo. These ﬁndings, together with the increased
inﬁltration of neutrophils in Fas- and FasL-deﬁcient mice,
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Epithelium
Fas
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Model on the role of Fas/FasL during epithelial HSV-2 infection
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Figure 8 Schematicmodel on therole of Fas/FasLpathway in regulationof local inﬂammation duringHSV-2infection of epithelium. Uponstimulationby FasL-expressing
cells, Fas-expressing cells respond by producing proinﬂammatory cytokines. Autocrine upregulation of FasL by epithelial cells, however, appears to block the effects of
extrinsicFasstimulation.HSV-2infectedcells,althoughupregulatingFasandFasLexpressiongainanapoptosisresistantstatusduetoupregulationofanti-apoptoticproteins
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Cell Death and Diseasesuggest that HSV-2-infected cells within the epithelium may
be resistant to apoptosis and that Fas/FasL interactions may
serve as a mechanism to reduce inﬂammation (Figure 8).
Depletion of Fas and FasL did not lead to signiﬁcant
changes of HSV-2 titers in the vaginal ﬂuid. It is, however,
possible that Fas-dependent pathway may still inﬂuence the
amounts of virus retained within the tissue and affect its
latency in the ganglia. In this respect, Ishikawa et al.
38
examined HSV-2 lethal infection in Fas- or FasL-deﬁcient
mice. Both the latter types of mice exhibited higher mortality
than WT C57BL/6 mice after HSV-2 infection and showed
signiﬁcantly increased viral titers in the spinal cord compared
with WT mice. However, the study
38 did not assess vaginal
histology.
Lack of Fas and FasL in knockout mice increased the
numbers of apoptotic-infected cells found at the infection
sites, but decreased the numbers of uninfected cells under-
going apoptosis. However, in the deﬁcient mice, the sites
without any visible inﬁltration of neutrophils corresponded to
siteswithscarceorabsentapoptoticcells;onthecontrary,the
sites with inﬁltration showed signiﬁcantly higher amounts of
apoptotic cells in comparison with similar sites found in HSV-2-
infected WT mice. Neutrophils are the early and predominant
innate immune cells, which may contribute to virus clearance
through the release of the antiviral cytokines TNF-a, IFN-a,
IFN-g, GM-CSF or oxygen and nitrogen metabolites.
37
However, neutrophil-induced tissue damage by release of
oxidants and proteases seen during inﬂammation can be
controlledin partbyneutrophil apoptosis,
39 in whichFas/FasL
pathway have an important role.
39 Our study shows that lack
of Fas and FasL in HSV-2-infected mice resulted in lack of
control of the local inﬂammation induced by neutrophils,
facilitating for apoptosis induction. Fas/FasL pathway in the
vaginal mucosa appears to participate in the regulation of the
local inﬂammation. Upon stimulation with extrinsic source of
FasL (like NK cells, cytotoxic T cells, etc.), Fas-expressing
cells produce proinﬂammatory cytokines, promoting the
recruitment of neutrophils, NK cells and macrophages.
However, the upregulation of FasL by epithelial cells appears
to block the effects of extrinsic Fas stimulation, probably
functioning as a self-regulatory mechanism. Fas and FasL
upregulation by HSV-2 infected cells appears to have the role
of protecting the virus from the effects of immune competent
cells inﬁltrating the HSV-2 lesion, thus ensuring virus survival
and further spreading (Figure 8).
Materials and Methods
Virus. The HSV-2 strain 333 was grown and titrated in African green monkey
kidneycells(GMK-AH1) andpreparedby one cycleof freeze–thawand subsequent
removal of cellular debris by centrifugation.
40
Cell lines and in vitro HSV-2 infection. The mouse epithelial Hepa 1–6
cells and mouse keratinocyte cell line 291.03C were kindly provided by M Kulesz-
Martin (Department of Dermatology, Oregon Health and Science University,
Portland, OR, USA). Hepa 1–6 cells were maintained in Dulbecco’s modiﬁed Eagle
medium (Thermo Fisher Scientiﬁc, Lafayette, CO, USA) with 5% glucose, 10% fetal
bovineserum(FBS)and1%antibiotics(ThermoFisherScientiﬁc).The291.03Cline
is a 7,12-dimethylbenz[a]anthracene-initiated clone, derived from non-transformed
291 cells
41 and was cultured in DMEM supplemented with 5% FBS (Thermo Fisher
Scientiﬁc), 10ng/ml epidermal growth factor (Sigma, St. Louis, MO, USA) and 1%
antibiotic(Sigma).ThecelllineswereinfectedwithHSV-2333strainatMOI¼10or
0.1, incubated for up to 48h and then collected by trypsinization or scratching. The
cells were further stained with antibodies for external and internal antigens.
Apoptosis detection. Early apoptosis was detected using Annexin
V-Apoptosis detection kit I (BD Biosciences, Franklin Lakes, NJ, USA), according
to the producer’s protocol. The annexin V-positive, propidium iodide-negative cells
were scored as apoptotic cells, whereas all propidium iodide-positive cells were
considered to be necrotic when analyzed in FACS Scan (BD Biosciences).
Staurosporine at 5mM was used as an inductor of apoptosis (positive control). To
detect executive phase of apoptosis, M30 CytoDEATH Fluorescein kit was used
(Roche, Indianapolis, IN, USA); the M30 antibodycytoDEATHrecognizesa speciﬁc
cleavage site within cytokeratin 18 that is not detectable in native cytokeratin 18 of
normal cells. Before staining, the samples were permeabilized with Cytoﬁx/
Cytoperm ﬁxation/permeabilization kit (BD Biosciences), according to the
manufacturer’s protocol and once stained, analyzed in FACS Scan (BD
Biosciences) or with Leica ﬂuorescence microscope equipped with Hamatsu
C4880 cold CCD camera (Leica Microsystems GmbH, Wetzlar, Germany), after
mounting in medium containing Hoechst 33342 (1mg/ml) (Sigma).
Antibodies and immunostaining. For detection of cell surface antigens
Fas and FasL, infected cells were collected by trypsinization and washed in 1%
FBS/PBS. FITC-conjugated monoclonal hamster anti-mouse Fas antibody and PE-
conjugated monoclonal hamster anti-mouse FasL antibody were used to detect
surface expression of Fas and FasL (BD Biosciences). Intra-cellular antigens were
detected using Cytoﬁx/Cytoperm ﬁxation/permeabilization kit (BD Biosciences),
according to the manufacturer’s protocol and by using the following antibodies:
FITC-conjugated monoclonal hamster anti-Bcl-2 antibody (BD Biosciences),
PE-conjugated monoclonal mouse anti-p65-NF-kB antibody (BD Biosciences)
and polyclonal rabbit anti-p-Akt (Ser 473) (Santa Cruz Biotechnology, Santa Cruz,
CA, USA). HSV-2 antigens were detected using rabbit polyclonal HSV antibody
(Dako, Glostrup, Denmark). TNF-a, CXCL1/2 and IL-1b were detected using
Cytoﬁx/Cytoperm ﬁxation/permeabilization kit with Golgi plug (BD Biosciences) as
described above, using polyclonal goat anti-GRO a/b (CXCL1/2) antibody (Santa
Cruz Biotechnology), monoclonal hamster anti-IL-1b antibody (BD Biosciences)
and Alexa Fluor 488-conjugated monoclonal rat anti-TNF-a antibody (BD
Biosciences). Following incubation with primary antibodies, appropriate anti-rabbit
PE or FITC-conjugated anti-goat or anti-hamster antibodies were used, where
necessary (BD Biosciences).
Cell suspensions from the vaginal tissue were prepared as follows: vaginal
tissues were cut into small pieces with scissors and then treated with collagenase/
dispase (1mg/ml) (Roche) in Iscove’s medium at 371C for 40min. Treated tissues
were pressed through a 70mm cell strainer and washed in PBS. Gr-1-positive cells
were detected using anti-CD11c-APC (BD Biosciences) and anti-Ly-6G-PE (BD
Biosciences),Fas,FasLandHSV-2weredetectedasdescribedabove,usingFITC-
conjugatedantibodies. For all stainings, appropriate isotypecontrol antibodieswere
used.ThestainedcellsuspensionswereanalyzedinFACSScanforthepercentage
of positively stained cells and/or mean intensity of ﬂuorescence. The data were
further analyzed using FlowJo software (Celeza GmbH, Olten, Switzerland).
HSV-2 infection of mice. Female mice, 6- to 8-week old, were used for all
experiments.B6.MRL-Fas
lpr/J(Fas / )andB6Smn.C3-Fasl
gld/J(FasL / )mice
were purchased from Charles River (Dortmund, Germany). C57BL/6 mice were
used as controls. Mice were injected s.c. with 2.0mg/kg of medroxyprogesterone
(Depo-Provera; Upjohn, Puurs, Belgium) in 100ml of PBS. At 6 days later, the mice
were infected by intravaginal inoculation of 10
4PFU per mice (100 LD50) of HSV-2
strain 333 in 20ml of HBSS. The animals were kept in ventilated cages under
speciﬁcpathogen-freeconditionsat theDepartmentofExperimentalBiomedicineat
the Gothenburg University. The studies were approved by the Ethics Committee for
Animal Experimentation, Gothenburg, Sweden. At 3 days following intra-vaginal
HSV-2 infection, the animals were killed and the vaginal tissue was used for
preparation of cryostat sections.
Immunoﬂuorescence microscopy of animal tissue. Vaginal tissue
was removed, ﬁxed in 2% paraformaldehyde in PBS for 4h, then washed twice in
10% sucrose in PBS over 16h before freezing and cryosectioning. Slides were
washedinPBSandusedforapoptosisdetectionviaTUNEL(Millipore,Billerica,MA,
USA) or M30 CytoDEATH Fluorescein kit (Roche) according to appropriate
manufacturer’s protocols. TUNEL and M30 CytoDEATH Fluorescein detection of
apoptosis in tissues was followed by incubation with anti-HSV-2 antibody (1:50)
Fas/FasL role during HSV-2 genital infection
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Cell Death and Disease(Dako) and secondary anti-rabbit-IgG-PE antibody (Vector Laboratories,
Burlingame, CA, USA). For Fas, FasL, Bcl-2, IL-1b and CXCL1/2 and HSV-2
double stainings, the slides were blocked with 3% BSA in PBS/0.1% Tween for
30min and incubated overnight at 41C with anti-Bcl-2, anti-Fas, anti-FasL, anti-IL-
1b (1:100) (BD Biosciences) and anti-CXCL1/2 (1:100) (Santa Cruz
Biotechnology) and anti-HSV-2 (1:250) antibodies in 1% BSA in PBS/0.1%
Tween. This procedure was followed by 30min incubation with goat anti-rabbit IgG-
PE antibody (Dako) and goat anti-hamster-IgG-FITC or donkey anti-goat IgG-FITC
antibody (Santa Cruz Biotechnology) in 1% goat serum on PBS/0.1% Tween. After
mounting in medium containing Hoechst 33342 (1mg/ml), ﬂuorescence was
captured with Leica ﬂuorescence microscope equipped in Hamatsu C4880 cold
CCDcamera.Forallstainings,appropriateisotypecontrolantibodieswereused.An
HSV-2-infected site was deﬁned as the area of HSV-2 positive staining within the
epithelium and the surrounding inﬁltration of neutrophils, without the sub-mucosal
stromal layer.
Virus titration. The virus titers were determined as described by Namvar
et al.
42 Brieﬂy, a 118-nucleotide segment of the gB region from HSV-2 region was
ampliﬁed using a HSV-2 probe labeled with JOE (6-carboxy-40,50-dichloro-20,70-
dimethoxyﬂuorescein) in a real-time PCR instrument ABI Prism 7000 (Applied
Biosystems, Carlsbad, CA, USA) and titrated as described.
42
Neutrophils isolation and transwell migration assay. Neutrophils
were isolated as described by Siemsen et al.
43 and stained with PKH26 Red
Fluorescent Cell Linker Kit for General Cell Membrane Labeling (Sigma) as
indicated by the manufacturer. Purity of isolation was determined by Gr-1-positive
staining and measured by FACS. Neutrophils migration was assayed using 24 well
Transwell inserts (BD Biosciences) with 3mm pores. One million of isolated
neutrophils were loaded into the top well and allowed to migrate for 6h toward
keratinocytes treated with anti-Fas antibody, anti-FasL blocking antibody, HSV-2-
infected keratinocytes and HSV-2-infected keratinocytes treated with anti-Fas
antibody or anti-FasL blocking antibody. Migrated cells were then collected and
measured using FACS. Extent of migration was expressed as a migration index,
which was deﬁned as the number of cells that migrated in a particular assay by the
number of cells that migrated toward cells kept in standard tissue culture of
uninfected keratinocytes.
Statistical methods. Quantitative data were presented as means±S.E.M. In
the case of normal distribution of values, conﬁrmed by Shapiro’s test, statistical
comparisons were performed using the Student’s t-test. With non-Gaussian
distributions, non-parametric Kruskal–Wallis and Wilcoxon tests were applied. In
every analysis values of Po0.05 were considered signiﬁcant.
Conﬂict of interest
Dr. Chiodi owns stock in the company Imed AB. The present work was not ﬁnanced
from Imed AB. The other authors declare no conﬂict of interest.
Acknowledgements. This work was supported in part by grants from the
Swedish Medical Research Council, Swedish state under the ALF agreement,
KarolinskaInstitutet(toFC),EIFMarieCuriefellowshipno.221246(toMK),Torsten
and Ragnar So ¨derbergs Research Foundation (to KE) and IngaBritt and Arne
Lundbergs Research Foundation (to KE).
1. Koyama AH, Adachi A. Induction of apoptosis by herpes simplex virus type 1. J Gen Virol
1997; 78: 2909–2912.
2. Koyama AH, Akari H, Adachi A, Goshima F, Nishiyama Y. Induction of apoptosis in HEp-2
cells by infection with herpes simplex virus type 2. Arch Virol 1998; 143: 2435–2441.
3. Ozaki N, Sugiura Y, Yamamoto M, Yokoya S, Wanaka A, Nishiyama Y. Apoptosis induced
in the spinal cord and dorsal root ganglion by infection of herpes simplex virus type 2 in the
mouse. Neurosci Lett 1997; 228: 99–102.
4. Fleck M, Mountz JD, Hsu HC, Wu J, Edwards III CK, Kern ER. Herpes simplex virus type 2
infection induced apoptosis in peritoneal macrophages independent of Fas and tumor
necrosis factor-receptor signaling. Viral Immunol 1999; 12: 263–275.
5. Mastino A, Sciortino MT, Medici MA, Perri D, Ammendolia MG, Grelli S et al. Herpes
simplex virus 2 causes apoptotic infection in monocytoid cells. Cell Death Differ 1997; 4:
629–638.
6. Jones CA, Fernandez M,Herc K,Bosnjak L,Miranda-SaksenaM, Boadle RAetal. Herpes
simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic
cells in vitro. J Virol 2003; 77: 11139–11149.
7. Han JY, Sloan DD, Aubert M, Miller SA, Dang CH, Jerome KR. Apoptosis and antigen
receptor function in T and B cells following exposure to herpes simplex virus. Virology
2007; 359: 253–263.
8. HataS,Koyama AH,ShiotaH,AdachiA,GoshimaF,NishiyamaY.Antiapoptoticactivityof
herpes simplex virus type 2: the role of US3 protein kinase gene. Microbes Infect 1999; 1:
601–607.
9. Perkins D, Pereira EF, Aurelian L. The herpes simplex virus type 2 R1 protein kinase
(ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons
involving activation of the ERK survival pathway and upregulation of the antiapoptotic
protein Bag-1. J Virol 2003; 77: 1292–1305.
10. Smith CC, Nelson J, Aurelian L, Gober M, Goswami BB. Ras-GAP binding and
phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/
MEK/MAPK mitogenic pathway are required for timely onset of virus growth. J Virol 2000;
74: 10417–10429.
11. Yedowitz JC, Blaho JA. Herpes simplex virus 2 modulates apoptosis and stimulates
NF-kappaB nuclear translocation during infection in human epithelial HEp-2 cells. Virology
2005; 342: 297–310.
12. Megyeri K, Orosz L, Kormos B, Pasztor K, Seprenyi G, Ocsovszki I et al. The herpes
simplex virus-induced demise of keratinocytes is associated with a dysregulated pattern of
p63 expression. Microbes Infect 2009; 11: 785–794.
13. Trautmann A, Akdis M, Kleemann D, Altznauer F, Simon HU, Graeve T et al. T cell-
mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role ineczematous
dermatitis. J Clin Invest 2000; 106: 25–35.
14. Lippens S, Hoste E, Vandenabeele P, Agostinis P, Declercq W. Cell death in the skin.
Apoptosis 2009; 14: 549–569.
15. Viard-Leveugle I, Bullani RR, Meda P, Micheau O, Limat A, Saurat JH et al. Intracellular
localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological
conditions. J Biol Chem 2003; 278: 16183–16188.
16. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D et al. Inhibition of toxic
epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.
Science 1998; 282: 490–493.
17. Farley SM, Dotson AD, Purdy DE, Sundholm AJ, Schneider P, Magun BE et al. Fas ligand
elicits a caspase-independent proinﬂammatory response in human keratinocytes:
implications for dermatitis. J Invest Dermatol 2006; 126: 2438–2451.
18. SiegS,YildirimZ,SmithD,KayagakiN,YagitaH,Huang Yetal.Herpessimplexvirus type
2 inhibition of Fas ligand expression. J Virol 1996; 70: 8747–8751.
19. Dobbs ME, Strasser JE, Chu CF, Chalk C, Milligan GN. Clearance of herpes simplex virus
type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated
cytolytic mechanisms. J Virol 2005; 79: 14546–14554.
20. Gober MD, Laing JM, Thompson SM, Aurelian L. The growth compromised HSV-2 mutant
DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic
hippocampal cultures. Brain Res 2006; 1119: 26–39.
21. Taylor TJ, Brockman MA, McNamee EE, Knipe DM. Herpes simplex virus. Front Biosci
2002; 7: 752–764.
22. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL. A mouse model for
studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest
1994; 70: 369–380.
23. Seitz CS, Freiberg RA, Hinata K, Khavari PA. NF-kappaB determines localization and
features of cell death in epidermis. J Clin Invest 2000; 105: 253–260.
24. Goodkin ML, Ting AT, Blaho JA. NF-kappaB is required for apoptosis prevention during
herpes simplex virus type 1 infection. J Virol 2003; 77: 7261–7280.
25. Medici MA, Sciortino MT, Perri D, Amici C, Avitabile E, Ciotti M et al. Protection by herpes
simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor
kappaB. J Biol Chem 2003; 278: 36059–36067.
26. Thrash BR, Menges CW, Pierce RH, McCance DJ. AKT1 provides an essential survival
signal required for differentiation and stratiﬁcation of primary human keratinocytes. J Biol
Chem 2006; 281: 12155–12162.
27. Laing JM, Smith CC, Aurelian L. Multi-targeted neuroprotection by the HSV-2 gene
ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-
dependent neuronal release of vascular endothelial growth factor and fractalkine.
J Neurochem 2010; 112: 662–676.
28. Benetti L, Roizman B. Protein kinase B/Akt is present in activated form throughout the
entire replicative cycle of deltaU(S)3 mutant virus but only at early times after infection with
wild-type herpes simplex virus 1. J Virol 2006; 80: 3341–3348.
29. Sciortino MT, Perri D, Medici MA, Grelli S, Seraﬁno A, Borner C et al. Role of Bcl-2
expression for productive herpes simplex virus 2 replication. Virology 2006; 356: 136–146.
30. Morton ER, BlahoJA. Herpes simplexvirus blocks Fas-mediatedapoptosisindependent of
viral activation of NF-kappaB in human epithelial HEp-2 cells. J Interferon Cytokine Res
2007; 27: 365–376.
31. Vanden Oever MJ, Han JY. Caspase 9 is essential for herpes simplex virus type 2-induced
apoptosis in T cells. J Virol 2010; 84: 3116–3120.
32. Krammer PH. CD95’s deadly mission in the immune system. Nature 2000; 407: 789–795.
33. Hohlbaum AM, Saff RR, Marshak-Rothstein A. Fas-ligand – iron ﬁst or Achilles’ heel? Clin
Immunol 2002; 103: 1–6.
Fas/FasL role during HSV-2 genital infection
M Krzyzowska et al
11
Cell Death and Disease34. Kleber S, Sancho-Martinez I, Wiestler B, Beisel A, Gieffers C, Hill O et al. Yes and PI3K
bind CD95 to signal invasion of glioblastoma. Cancer Cell 2008; 13: 235–248.
35. Thapa M, Carr DJ. Chemokines and chemokine receptors critical to host resistance
following genital herpes simplex virus type 2 (HSV-2) infection. Open Immunol J 2008; 1:
33–41.
36. Peng T, Zhu J, Klock A, Phasouk K, Huang ML, Koelle DM et al. Evasion of the mucosal
innate immune system by herpes simplex virus type 2. J Virol 2009; 83: 12559–12568.
37. Milligan GN, Bourne N, Dudley KL. Role of polymorphonuclear leukocytes in resolution of
HSV-2 infection of the mouse vagina. J Reprod Immunol 2001; 49: 49–65.
38. Ishikawa T, Yamada H, Oyamada A, Goshima F, Nishiyama Y, Yoshikai Y. Protective role
of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice.
J Virol 2009; 83: 11777–11783.
39. AkgulC,EdwardsSW.Regulationofneutrophilapoptosisviadeathreceptors.CellMolLife
Sci 2003; 60: 2402–2408.
40. Svensson A, Nordstrom I, Sun JB, Eriksson K. Protective immunity to genital herpes
simplex virus type 2 infection is mediated by T-bet. J Immunol 2005; 174: 6266–6273.
41. Kulesz-Martin M, Yoshida MA, Prestine L, Yuspa SH, Bertram JS. Mouse cell clones for
improved quantitation of carcinogen-induced altered differentiation. Carcinogenesis 1985;
6: 1245–1254.
42. Namvar L,Olofsson S, Bergstrom T, Lindh M. Detection and typing of herpes simplex virus
(HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous
for HSV types 1 and 2. J Clin Microbiol 2005; 43: 2058–2064.
43. Siemsen DW, Schepetkin IA, Kirpotina LN, Lei B, Quinn MT. Neutrophil isolation from
nonhuman species. Methods Mol Biol 2007; 412: 21–34.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under the Creative Commons Attribution-Noncommercial-No
DerivativeWorks3.0Unported License. To viewacopyofthis license,
visit http://creativecommons.org/licenses/by-nc-nd/3.0/
Fas/FasL role during HSV-2 genital infection
M Krzyzowska et al
12
Cell Death and Disease